Veterinary Medicine Information website

ALFAMED FIPRONIL 268 MG SPOT-ON SOLUTION FOR LARGE DOGS

Authorised
  • Fipronil
Download as PDF

Product identification

Medicine name:
ALFAMED FIPRONIL 268 MG SPOT-ON SOLUTION FOR LARGE DOGS
Active substance:
  • Fipronil
Target species:
  • Dog
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Fipronil
    268.00
    milligram(s)
    /
    1.00
    Pipette
Pharmaceutical form:
  • Spot-on solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX15
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:
  • Box containing 1 pipette of 2.68 mL
  • Box containing 150 blister packs of 1 pipette of 2.68 mL
  • Box containing 90 blister packs of 1 pipette of 2.68 mL
  • Box containing 60 blister packs of 1 pipette of 2.68 mL
  • Box containing 30 blister packs of 1 pipette of 2.68 mL
  • Box containing 24 blister packs of 1 pipette of 2.68 mL
  • Box containing 12 blister packs of 1 pipette of 2.68 mL
  • Box containing 12 blister packs of 1 pipette of 2.68 mL
  • Box containing 12 blister packs of 1 pipette of 2.68 mL
  • Box containing 12 blister packs of 1 pipette of 2.68 mL
  • Box containing 12 blister packs of 1 pipette of 2.68 mL
  • Box containing 12 blister packs of 1 pipette of 2.68 mL
  • Box containing 150 pipettes of 2.68 mL
  • Box containing 90 pipettes of 2.68 mL
  • Box containing 60 pipettes of 2.68 mL
  • Box containing 30 pipettes of 2.68 mL
  • Box containing 24 pipettes of 2.68 mL
  • Box containing 12 pipettes of 2.68 mL
  • Box containing 8 pipettes of 2.68 mL
  • Box containing 6 pipettes of 2.68 mL
  • Box containing 4 pipettes of 2.68 mL
  • Box containing 3 pipettes of 2.68 mL
  • Box containing 2 pipettes of 2.68 mL
  • Box containing 6 blister packs of 1 pipette of 2.68 mL

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Alfamed
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfamed
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 104068
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0380/003
Concerned member states:
  • Italy
  • Netherlands
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 13/03/2026
Download
Italian (PDF)
Published on: 7/09/2023
Updated on: 9/09/2023
Download